92 related articles for article (PubMed ID: 16965334)
1. Overexpression of MLH-1 and psoriasin genes in cutaneous angiofibromas from tuberous sclerosis complex patients.
La Placa M; Gibellini D; Bianchi T; Patrizi A
J Cutan Pathol; 2006 Sep; 33(9):608-13. PubMed ID: 16965334
[TBL] [Abstract][Full Text] [Related]
2. Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.
Tyburczy ME; Wang JA; Li S; Thangapazham R; Chekaluk Y; Moss J; Kwiatkowski DJ; Darling TN
Hum Mol Genet; 2014 Apr; 23(8):2023-9. PubMed ID: 24271014
[TBL] [Abstract][Full Text] [Related]
3. Expression of proteoglycans and glycosaminoglycans in angiofibroma and fibrous plaque skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Pesintzaki C; Minas A; Karakiulakis G
Arch Dermatol Res; 2003 Aug; 295(4):138-45. PubMed ID: 12844226
[TBL] [Abstract][Full Text] [Related]
4. Angiofibromas with multiple epidermoid cysts in tuberous sclerosis: new mutation or post-traumatic?
Zheng LQ; Huang Y; Han XC
J Cutan Pathol; 2013 May; 40(5):509-12. PubMed ID: 23418925
[TBL] [Abstract][Full Text] [Related]
5. MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
Li S; Takeuchi F; Wang JA; Fuller C; Pacheco-Rodriguez G; Moss J; Darling TN
J Exp Med; 2005 Sep; 202(5):617-24. PubMed ID: 16129702
[TBL] [Abstract][Full Text] [Related]
6. Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis.
Kacerovska D; Kerl K; Michal M; Filipova H; Vrtel R; Vanecek T; Zelenakova H; Kraus J; Kodet R; Kazakov DV
J Am Acad Dermatol; 2012 Dec; 67(6):1319-26. PubMed ID: 22552000
[TBL] [Abstract][Full Text] [Related]
7. Cellular senescence of angiofibroma stroma cells from patients with tuberous sclerosis.
Toyoshima M; Ohno K; Katsumoto T; Maki H; Takeshita K
Brain Dev; 1999 Apr; 21(3):184-91. PubMed ID: 10372905
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas.
Li S; Takeuchi F; Wang JA; Fan Q; Komurasaki T; Billings EM; Pacheco-Rodriguez G; Moss J; Darling TN
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3539-44. PubMed ID: 18292222
[TBL] [Abstract][Full Text] [Related]
9. RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer.
Emberley ED; Gietz RD; Campbell JD; HayGlass KT; Murphy LC; Watson PH
BMC Cancer; 2002 Nov; 2():28. PubMed ID: 12421467
[TBL] [Abstract][Full Text] [Related]
10. Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
Balestri R; Neri I; Patrizi A; Angileri L; Ricci L; Magnano M
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):14-20. PubMed ID: 25174683
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
[TBL] [Abstract][Full Text] [Related]
12. [Tuberous sclerosis in childhood].
Pires CF; Anunciação GM; De Sousa WL; Santos BM; Anunciação FA; Pires AF; Pires LF
Dermatol Online J; 2008 Sep; 14(9):14. PubMed ID: 19061596
[TBL] [Abstract][Full Text] [Related]
13. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
14. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A
Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939
[TBL] [Abstract][Full Text] [Related]
15. Establishment of Tsc2‑deficient rat embryonic stem cells.
Ito Y; Kawano H; Kanai F; Nakamura E; Tada N; Takai S; Horie S; Arai H; Kobayashi T; Hino O
Int J Oncol; 2015 May; 46(5):1944-52. PubMed ID: 25738543
[TBL] [Abstract][Full Text] [Related]
16. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.
Darling TN; Skarulis MC; Steinberg SM; Marx SJ; Spiegel AM; Turner M
Arch Dermatol; 1997 Jul; 133(7):853-7. PubMed ID: 9236523
[TBL] [Abstract][Full Text] [Related]
17. Tuberous sclerosis complex: multisystem hamartomas.
Naderi N; Timofte I; McCurdy MT; Reed RM
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25618887
[No Abstract] [Full Text] [Related]
18. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
19. Mutation screening of the entire coding regions of the TSC1 and the TSC2 gene with the protein truncation test (PTT) identifies frequent splicing defects.
Mayer K; Ballhausen W; Rott HD
Hum Mutat; 1999; 14(5):401-11. PubMed ID: 10533066
[TBL] [Abstract][Full Text] [Related]
20. Analysis of twenty pediatric cases of tuberous sclerosis complex: are we doing enough?
Nath J; Dubey A; Pavan R
Indian J Dermatol Venereol Leprol; 2015; 81(1):23-8. PubMed ID: 25566892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
